{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:44:49Z","timestamp":1785545089088,"version":"3.56.0"},"reference-count":24,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Public Health Surveill"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Chronic hepatitis B (CHB) remains a significant health burden for at least a hundred thousand Canadians. The government of Canada has endorsed the global strategy to eliminate hepatitis as a public health threat by 2030, but effectively targeting public health interventions is complicated by the silent nature of the disease, which can remain asymptomatic for decades.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study develops a framework to estimate the prevalence of CHB and the proportion of the infected population that remains undiagnosed. We apply the proposed method to national data from Canada, from 2007 to 2021.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We infer the prevalence and undiagnosed proportion of CHB by fitting a mathematical state-transition model, based on the natural history of CHB, to observed CHB-related events. Data for the calibration were obtained from the Public Health Agency of Canada and Statistics Canada.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n We estimate the national prevalence of CHB in Canada in 2021 to be 0.483% (95% CI 0.443%-0.535%). The corresponding percentage of undiagnosed cases was estimated to be 54.3% (95% CI 50.9%-58.9%).<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The estimates of CHB prevalence obtained via our method are in line with previous estimates obtained from national seroprevalence studies. More specialized estimates, stratified by province or age cohort, may be achievable with detailed health administrative data.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/66309","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:38:20Z","timestamp":1746171500000},"page":"e66309-e66309","source":"Crossref","is-referenced-by-count":0,"title":["Estimating Chronic Hepatitis B Prevalence and Undiagnosed Proportion in Canada, 2007-2021: Mathematical Framework Development"],"prefix":"10.2196","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8734-0896","authenticated-orcid":false,"given":"Julien","family":"Smith-Roberge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1833-823X","authenticated-orcid":false,"given":"Farinaz","family":"Forouzannia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9419-1797","authenticated-orcid":false,"given":"Abdullah","family":"Hamadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8113-3619","authenticated-orcid":false,"given":"Zeny","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3841-5841","authenticated-orcid":false,"given":"Nashira","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4630-0052","authenticated-orcid":false,"given":"William W L","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"R1","unstructured":"World Health Organization. Hepatitis B: Fact Sheet. 2024. URL: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/hepatitis-b [Accessed 30-04-2024]"},{"key":"R2","unstructured":"Message from the Minister of Health - World Hepatitis Day. Government of Canada. 2016. URL: https:\/\/www.canada.ca\/en\/health-canada\/news\/2016\/07\/message-from-the-minister-of-health-world-hepatitis-day.html [Accessed 30-04-2024]"},{"issue":"11","key":"R3","first-page":"3","volume":"24","author":"Rotermann","journal-title":"Health Rep"},{"key":"R4","unstructured":"Government of Canada. Highlights from the 2021 childhood National Immunization Coverage Survey. 2023. URL: https:\/\/www.canada.ca\/en\/public-health\/services\/immunization-vaccines\/vaccination-coverage\/2021-highlights-childhood-national-immunization-coverage-survey.html [Accessed 30-04-2024]"},{"key":"R5","unstructured":"Government of Canada. Provincial and territorial routine and catch-up vaccination schedule for infants and children in Canada. 2023. URL: https:\/\/www.canada.ca\/en\/public-health\/services\/provincial-territorial-immunization-information\/provincial-territorial-routine-vaccination-programs-infants-children.html [Accessed 30-04-2024]"},{"issue":"Suppl 3","key":"R6","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.3949\/ccjm.76.s3.06","article-title":"Management of hepatitis B in pregnancy: weighing the options","volume":"76 Suppl 3","author":"Tran","journal-title":"Cleve Clin J Med"},{"key":"R7","unstructured":"Statistics Canada. Table 98-10-0349-01 Place of birth and period of immigration by gender and age. 2023. URL: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=9810034901 [Accessed 25-03-2025]"},{"key":"R8","unstructured":"Ontario Agency for Health Protection and Promotion (Public Health Ontario). Immunization Coverage Report for School-Based Programs in Ontario: 2019-20, 2020-21 and 2021-22 School Years with Impact of Catch-up Programs. King\u2019s Printer for Ontario; 2023."},{"issue":"43","key":"R9","doi-asserted-by":"publisher","first-page":"E1299","DOI":"10.1503\/cmaj.200290","article-title":"Prenatal hepatitis B screening, and hepatitis B burden among children, in Ontario: a descriptive study","volume":"192","author":"Biondi","journal-title":"Can Med Assoc J"},{"issue":"11","key":"R10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225366","article-title":"A model-based framework for chronic hepatitis C prevalence estimation","volume":"14","author":"Hamadeh","journal-title":"PLoS One"},{"issue":"19","key":"R11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.14745\/ccdr.v40i19a02","article-title":"Estimated prevalence of Hepatitis C Virus infection in Canada, 2011","volume":"40","author":"Trubnikov","journal-title":"Can Commun Dis Rep"},{"issue":"6","key":"R12","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/sim.4780110612","article-title":"Estimating the stage\u2010specific numbers of HIV infection using a markov model and back\u2010calculation","volume":"11","author":"Longini","journal-title":"Stat Med"},{"issue":"9","key":"R13","doi-asserted-by":"publisher","DOI":"10.2196\/26409","article-title":"Estimation of COVID-19 period prevalence and the undiagnosed population in Canadian Provinces: model-based analysis","volume":"7","author":"Hamadeh","journal-title":"JMIR Public Health Surveill"},{"key":"R14","unstructured":"Kim J . Model-based estimation of the prevalence of chronic hepatitis B in Canada and cost-effectiveness analysis of implementing a universal birth hepatitis B vaccination program in Ontario, Canada. University of Waterloo; 2022."},{"issue":"4","key":"R15","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","journal-title":"Hepatology"},{"key":"R16","unstructured":"Statistics Canada. Table 13-10-0111-01\u2014Number and rates of new cases of primary cancer, by cancer type, age group and sex. 2024. URL: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1310011101 [Accessed 30-04-2024]"},{"key":"R17","unstructured":"Public Health Agency of Canada. Notifiable Diseases Online. 2024. URL: https:\/\/diseases.canada.ca\/notifiable\/ [Accessed 30-04-2024]"},{"issue":"6","key":"R18","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1002\/hep.31557","article-title":"Diagnosis of chronic hepatitis B pericomplication: risk factors and trends over time","volume":"73","author":"Lapointe-Shaw","journal-title":"Hepatology"},{"issue":"8","key":"R19","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1478-3231.2011.02559.x","article-title":"Cost effectiveness of screening immigrants for hepatitis B","volume":"31","author":"Wong","journal-title":"Liver Int"},{"issue":"1","key":"R20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/biomet\/57.1.97","article-title":"Monte Carlo sampling methods using Markov chains and their applications","volume":"57","author":"Hastings","journal-title":"Biometrika"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.17601.2","article-title":"Sexual dimorphism in chronic hepatitis B virus (HBV) infection: evidence to inform elimination efforts","volume":"7","author":"Brown","journal-title":"Wellcome Open Res"},{"key":"R22","unstructured":"Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Prevalence and epidemiology of hepatitis B; 2022. URL: https:\/\/hepatitisb.org.au\/prevalence-and-epidemiology-of-hepatitis-b\/ [Accessed 25-03-2025]"},{"key":"R23","unstructured":"European Centre for Disease Prevention and Control. Systematic review on hepatitis B and C prevalence in the EU\/EEA. 2016. URL: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/systematic-review-hepatitis-b-and-c-prevalence-eueea [Accessed 25-03-2025]"},{"key":"R24","unstructured":"European Centre for Disease Prevention and Control. ECDC: around 9 million Europeans are affected by chronic hepatitis B or C. 2017. URL: https:\/\/www.ecdc.europa.eu\/en\/news-events\/ecdc-around-9-million-europeans-are-affected-chronic-hepatitis-b-or-c [Accessed 25-03-2025]"}],"container-title":["JMIR Public Health and Surveillance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publichealth.jmir.org\/2025\/1\/e66309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:28:55Z","timestamp":1785536935000},"score":1,"resource":{"primary":{"URL":"https:\/\/publichealth.jmir.org\/2025\/1\/e66309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":24,"URL":"https:\/\/doi.org\/10.2196\/66309","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.66309","asserted-by":"object"}]},"ISSN":["2369-2960"],"issn-type":[{"value":"2369-2960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"article-number":"v11i11e66309"}}